Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006-Reference-Cited by-同舟云学术

Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006

Published:2015-02-26 Issue:5 Volume:137 Page:1217-1223
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Chihara Dai¹²,Ito Hidemi¹,Izutsu Koji³,Hattori Masakazu⁴,Nishino Yoshikazu⁵,Ioka Akiko⁶,Matsuda Tomohiro⁷,Ito Yuri⁶

Affiliation:

1. Division of Epidemiology and Prevention; Aichi Cancer Center Research Institute; Nagoya Japan

2. Department of Lymphoma and Myeloma; MD Anderson Cancer Center; Houston TX

3. Department of Hematology; Toranomon Hospital; Tokyo Japan

4. Department of Cancer Therapy Center; Fukui Prefectural Hospital; Fukui Japan

5. Division of Cancer Epidemiology and Prevention; Miyagi Cancer Center Research Institute; Natori Japan

6. Center for Cancer Control and Statistics; Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka Japan

7. Division of Surveillance; Center for Cancer Control and Information Services, National Cancer Center; Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century;Brenner;Blood,2008

2. Recent major improvement in long-term survival of younger patients with multiple myeloma;Brenner;Blood,2008

3. Survival expectations of patients diagnosed with Hodgkin's lymphoma in 2006-2010;Brenner;Oncologist,2009

4. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century;Pulte;Arch Intern Med,2008

5. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005;Pulte;Cancer,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma;Laboratory Investigation;2024-04

2. Advancements of Biometrics in the Field of Epidemiology;Japanese Journal of Biometrics;2024

3. The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis;Cancer Chemotherapy and Pharmacology;2023-11-03

4. Conditional survival in multiple myeloma and impact of prognostic factors over time;Blood Cancer Journal;2023-05-15

5. Conditional Survival in Multiple Myeloma and Impact of Prognostic Factors Over Time;2022-11-04